Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ImmunityBio, Inc. | Former Director | Common Stock | 202K | $1.02M | $5.02 | Feb 23, 2021 | Direct |
ImmunityBio, Inc. | Former Director | Common Stock | 13.9K | $69.7K | $5.02 | Dec 31, 2021 | Indirect |
Virios Therapeutics, Inc. | Director | Stock Option (right to buy) | 4.17K | Feb 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIRI | Virios Therapeutics, Inc. | Feb 26, 2024 | 1 | $0 | 4 | Feb 28, 2024 | Director |
VIRI | Virios Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
VIRI | Virios Therapeutics, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 30, 2022 | Director |
VIRI | Virios Therapeutics, Inc. | Jan 4, 2022 | 1 | $5.65K | 4 | Jan 4, 2022 | Director |
IBRX | ImmunityBio, Inc. | Dec 31, 2021 | 1 | $0 | 5 | Jan 28, 2022 | Former Director |
VIRI | Virios Therapeutics, Inc. | Jun 22, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Director |